When medically indicated, tirzepatide may help support weight loss by:

• Reducing appetite and food cravings.

• Promoting a feeling of fullness after meals.

• Supporting metabolic regulation.

• Encouraging gradual, sustained weight loss when combined with lifestyle changes.

Individual responses vary.

Tirzepatide may cause side effects in some individuals. A medical consultation is required to review potential risks, benefits, and contraindications.

• Tirzepatide is intended to be used alongside a reduced‑calorie diet and increased physical activity, not as a stand‑alone solution.​

• The most common side effects are usually mild‑to‑moderate gastrointestinal symptoms such as nausea, vomiting, or diarrhea, which tend to occur during dose increases and often lessen over time.

A structured, medically supervised program designed for steady, sustainable progress. You’ll receive weekly subcutaneous injections with ongoing follow-ups, and your dose will be gradually adjusted based on your tolerance, keeping the focus on long-term weight management rather than rapid, short-term loss.

Tirzepatide generally produces greater average weight loss than semaglutide at their obesity doses, but both are highly effective options and share similar gastrointestinal side effects and safety considerations. The choice between them often comes down to how much weight loss is needed, individual tolerance, access, and cost rather than efficacy alone.

Head‑to‑head trial data

• Across multiple datasets, adults with obesity tend to lose a higher percentage of body weight on tirzepatide than on semaglutide when each is used at its typical obesity dose range.​

• In the SURMOUNT‑5 head‑to‑head trial (non‑diabetic adults with obesity/overweight), average weight loss at 72 weeks was about 20.2% with tirzepatide versus 13.7% with semaglutide.​

• A press summary of that trial reported that roughly one‑third of people on tirzepatide reached at least 25% weight loss, compared with about one‑sixth of those on semaglutide.

Medical weight loss may be appropriate for adults who:

• Have difficulty losing weight despite lifestyle efforts.

• Are seeking a structured, medically supervised program.

• Want a long-term approach rather than short-term dieting.

• May benefit from additional metabolic support under medical care.

Eligibility is determined through medical consultation.

You may be a good candidate for a medically supervised weight loss program if you:

• Have struggled to lose weight despite consistent diet and lifestyle efforts

• Are looking for a structured, physician-guided approach rather than a commercial diet plan

• Want a safe, evidence-based option focused on long-term weight management

• Are willing to participate in ongoing medical monitoring and follow-up

• Understand that weight loss results vary and require commitment to the program

Medical weight loss is not a one-size-fits-all solution. Eligibility is determined through a medical evaluation, which includes a review of your health history, current medications, and overall goals.